The analysis of the transcriptome as a new approach for biomarker development to trace the abuse of anabolic steroid hormones

Drug Testing and Analysis

Volumn 3, Issue 10, 2011, Pages 676-681

  Riedmaier, Irmgard ^a   Pfaffl, Michael W ^a   Meyer, Heinrich H D ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Anabolic steroids; Gene expression biomarkers; RT qPCR

Indexed keywords

BIOMARKERS; ENDOCRINOLOGY; HISTOLOGY; MASS SPECTROMETRY; POLYMERASE CHAIN REACTION; STEROID HORMONES; TISSUE; TISSUE ENGINEERING;

ANABOLIC STEROID; ANIMAL HUSBANDRY; CONTROL PROGRAM; GENE EXPRESSION BIOMARKER; GENES EXPRESSION; GROWTH PROMOTERS; NEW APPROACHES; RT-QPCR; SCREENING METHODS; TRANSCRIPTOMES;

GENE EXPRESSION;

ANABOLIC AGENT; ANDROGEN; ANDROGEN RECEPTOR; CASPASE 8; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; KERATINOCYTE GROWTH FACTOR; MESSENGER RNA; SELECTIVE ANDROGEN RECEPTOR MODULATOR; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STEROID 5ALPHA REDUCTASE 2; TRANSCRIPTOME; STEROID;

BIOSTATISTICS; DRUG ABUSE; DRUG MISUSE; GENE EXPRESSION; HAIR FOLLICLE; HUMAN; IMMUNOASSAY; MASS SPECTROMETRY; MUSCLE ATROPHY; NONHUMAN; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SCREENING; SHORT SURVEY; TISSUE DISTRIBUTION; ANIMAL; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; METHODOLOGY; REVIEW; SUBSTANCE ABUSE;

ANABOLIC AGENTS; ANIMALS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; STEROIDS; SUBSTANCE ABUSE DETECTION; TRANSCRIPTOME;

EID: 84857066037     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.304     Document Type: Short Survey

References (53)

1. W.R. Dayton, M.E. White Cellular and molecular regulation of muscle growth and development in meat animals. J. Anim. Sci. 2008, 86, E217.
2. F.P. Moss, C.P. Leblond Satellite cells as the source of nuclei in muscles of growing rats. Anat. Rec. 1971, 170, 421.
3. D.R. Campion The muscle satellite cell: a review. Int. Rev. Cytol. 1984, 87, 225.
4. H.H.D. Meyer Biochemistry and physiology of anabolic hormones used for improvement of meat production. APMIS. 2001, 109, 1.
5. J. Balasch Sex steroids and bone: current perspectives. Hum. Reprod. Update. 2003, 9, 207.
6. J.E. Morley, M.J. Kim, M.T. Haren Frailty and hormones. Rev. Endocr. Metab. Disord. 2005, 6, 101.
7. J.S. Mayes, G.H. Watson Direct effects of sex steroid hormones on adipose tissues and obesity. Obes. Rev. 2004, 5, 197.
8. P.S. Cooke, A. Naaz Role of estrogens in adipocyte development and function. Exp. Biol. Med. 2004, 229, 1127.
9. P.G. De The adipose tissue metabolism: role of testosterone and dehydroepiandrosterone. Int. J. Obes. Relat. Metab. Disord. 2000, 24, S59.
10. H.H.D. Meyer, S. Hoffmann Development of a sensitive microtitration plate enzyme-immunoassay for the anabolic steroid trenbolone. Food Addit. Contam. 1987, 4, 149.
11. H.H.D. Meyer, L. Rinke, I. Dursch Residue screening for the beta-agonists clenbuterol, salbutamol and cimaterol in urine using enzyme immunoassay and high-performance liquid chromatography. J. Chromatogr. 1991, 564, 551.
12. M.L. Scippo, G. Degand, A. Duyckaerts, G. Maghuin-Rogister, P. Delahaut Control of the illegal administration of natural steroid hormones in the plasma of bulls and heifers. Analyst 1994, 119, 2639.
13. L.A. van Ginkel Immunoaffinity chromatography, its applicability and limitations in multi-residue analysis of anabolizing and doping agents. J. Chromatogr. 1991, 564, 363.
14. K.F. Becker, V. Metzger, S. Hipp, H. Hofler Clinical proteomics: new trends for protein microarrays. Curr. Med. Chem. 2006, 13, 1831.
15. J.A. Ludwig, J.N. Weinstein Biomarkers in cancer staging, prognosis and treatment selection. Nat. Rev. Cancer 2005, 5, 845.
16. S.E. Ilyin, S.M. Belkowski, C.R. Plata-Salaman Biomarker discovery and validation: technologies and integrative approaches. Trends Biotechnol. 2004, 22, 411.
17. X. Zhang, L. Li, D. Wei, Y. Yap, F. Chen Moving cancer diagnostics from bench to bedside. Trends Biotechnol. 2007, 25, 166.
18. I. Riedmaier, C. Becker, M.W. Pfaffl, H.H. Meyer The use of omic technologies for biomarker development to trace functions of anabolic agents. J. Chromatogr. A 2009, 1216, 8192.
19. M. Beato, S. Chavez, M. Truss Transcriptional regulation by steroid hormones. Steroids 1996, 61, 240.
20. D.P. Edwards Regulation of signal transduction pathways by estrogen and progesterone. Annu. Rev. Physiol. 2005, 67, 335.
21. A.W. Brandenberger, M.K. Tee, J.Y. Lee, V. Chao, R.B. Jaffe Tissue distribution of estrogen receptors alpha (ER-alpha) and beta (ER-beta) mRNA in the midgestational human fetus. J. Clin. Endocrinol. Metab. 1997, 82, 3509.
22. E. Enmark, M. Pelto-Huikko, K. Grandien, S. Lagercrantz, J. Lagercrantz, G. Fried, M. Nordenskjold, J.A. Gustafsson Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J. Clin. Endocrinol. Metab. 1997, 82, 4258.
23. C. Becker, I. Riedmaier, M. Reiter, A. Tichopad, M.J. Groot, A.A. Stolker, M.W. Pfaffl, M.F. Nielen, H.H. Meyer Influence of anabolic combinations of an androgen plus an estrogen on biochemical pathways in bovine uterine endometrium and ovary. J. Steroid Biochem. Mol. Biol. 2011, 125, 3.
24. I. Riedmaier, M. Reiter, A. Tichopad, M.W. Pfaffl, H.H. Meyer The potential of bovine vaginal smear for biomarker development to trace the misuse of anabolic agents. Exp. Clin. Endocrinol. Diabetes. 2011, 119, 86.
25. M.W. Pfaffl, I.G. Lange, A. Daxenberger, H.H. Meyer Tissue-specific expression pattern of estrogen receptors (ER): quantification of ER alpha and ER beta mRNA with real-time RT-PCR. APMIS 2001, 109, 345.
26. M. Reiter, V.M. Walf, A. Christians, M.W. Pfaffl, H.H. Meyer Modification of mRNA expression after treatment with anabolic agents and the usefulness for gene expression-biomarkers. Anal. Chim. Acta 2007, 586, 73.
27. M. Iwamura, P.A. Abrahamsson, C.M. Benning, A.T. Cockett, P.A. di Sant'Agnese Androgen receptor immunostaining and its tissue distribution in formalin-fixed, paraffin-embedded sections after microwave treatment. J. Histochem. Cytochem. 1994, 42, 783.
28. A. Malucelli, H. Sauerwein, M.W. Pfaffl, H.H. Meyer Quantification of androgen receptor mRNA in tissues by competitive co-amplification of a template in reverse transcription-polymerase chain reaction. J. Steroid Biochem. Mol. Biol. 1996, 58, 563.
29. W.Y. Chang, G.S. Prins Estrogen receptor-beta: implications for the prostate gland. Prostate 1999, 40, 115.
30. M.W. Pfaffl, I.G. Lange, H.H. Meyer The gastrointestinal tract as target of steroid hormone action: quantification of steroid receptor mRNA expression (AR, ERalpha, ERbeta and PR) in 10 bovine gastrointestinal tract compartments by kinetic RT-PCR. J. Steroid Biochem. Mol. Biol. 2003, 84, 159.
31. C. Becker, I. Riedmaier, M. Reiter, A. Tichopad, M.W. Pfaffl, H.D. Meyer Heinrich Effect of trenbolone acetate plus estradiol on trqnscriptional regulation of metabolism pathways in bovine liver. Horm. Mol. Biol. Clin. Invest. 2011, 2, 257.
32. I. Riedmaier, A. Tichopad, M. Reiter, M.W. Pfaffl, H.H. Meyer Identification of potential gene expression biomarkers for the surveillance of anabolic agents in bovine blood cells. Anal. Chim. Acta 2009, 638, 106.
33. J.C. Marioni, C.E. Mason, S.M. Mane, M. Stephens, Y. Gilad RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. Genome. Res. 2008, 18, 1509.
34. Z. Wang, M. Gerstein, M. Snyder RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 2009, 10, 57.
35. S.A. Bustin, V. Benes, J.A. Garson, J. Hellemans, J. Huggett, M. Kubista, R. Mueller, T. Nolan, M.W. Pfaffl, G.L. Shipley, J. Vandesompele, C.T. Wittwer The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 2009, 55, 611.
36. K.S. Stenn, R. Paus Controls of hair follicle cycling. Physiol. Rev. 2001, 81, 449.
37. M. Reiter, M.W. Pfaffl, M. Schoenfelder, H.H.D. Meyer Gene expression in hair follicle dermal papilla cells after treatment with stanozolol. Biomarker Insights 2009, 4, 1.
38. M. Reiter, S. Lüderwald, M.W. Pfaffl, H.H.D. Meyer First steps towards a new screening method for anabolic androgenic agents in human hair follicle. Doping Journal 2008, 5, 3.
39. F.J. Lopez New approaches to the treatment of osteoporosis. Curr. Opin. Chem. Biol. 2000, 4, 383.
40. M.R. Deschenes Effects of aging on muscle fibre type and size. Sports Med. 2004, 34, 809.
41. T.J. Doherty Invited review: Aging and sarcopenia. J. Appl. Physiol. 2003, 95, 1717.
42. A. Negro-Vilar Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium. J. Clin. Endocrinol. Metab. 1999, 84, 3459.
43. I. Riedmaier, A. Tichopad, M. Reiter, M.W. Pfaffl, H.H. Meyer Influence of testosterone and a novel SARM on gene expression in whole blood of Macaca fascicularis. J. Steroid Biochem. Mol. Biol. 2009, 114, 167.
44. M. Reiter, A. Tichopad, I. Riedmaier, M.W. Pfaffl, H.D. Meyer Heinrich Monitoring gene expression in muscle tissue of macaca fascicularis under the influence of testosterone and SARM. Horm Mol Biol Clin Invest. 2010, 1, 73.
45. L. Toffolatti, G.L. Rosa, T. Patarnello, C. Romualdi, R. Merlanti, C. Montesissa, L. Poppi, M. Castagnaro, L. Bargelloni Expression analysis of androgen-responsive genes in the prostate of veal calves treated with anabolic hormones. Domest. Anim. Endocrinol. 2006, 30, 38.
46. C. Becker, I. Riedmaier, M. Reiter, A. Tichopad, M.W. Pfaffl, H.D. Meyer Heinrich Changes in the miRNA profile under the influence of anabolic steroids in bovine liver. Analyst 2011, 136, 1204.
47. H.M. Heneghan, N. Miller, M.J. Kerin MiRNAs as biomarkers and therapeutic targets in cancer. Curr. Opin. Pharmacol. 2010, 10, 543.
48. C.L. Bartels, G.J. Tsongalis MicroRNAs: novel biomarkers for human cancer. Clin. Chem. 2009, 55, 623.
49. J. Lu, G. Getz, E.A. Miska, E. varez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, B.L. Ebert, R.H. Mak, A.A. Ferrando, J.R. Downing, T. Jacks, H.R. Horvitz, T.R. Golub MicroRNA expression profiles classify human cancers. Nature 2005, 435, 834.
50. G. Lee, C. Rodriguez, A. Madabhushi Investigating the efficacy of nonlinear dimensionality reduction schemes in classifying gene and protein expression studies. IEEE/ACM. Trans. Comput. Biol. Bioinform. 2008, 5, 368.
51. M. Kubista, J.M. Andrade, M. Bengtsson, A. Forootan, J. Jonak, K. Lind, R. Sindelka, R. Sjoback, B. Sjogreen, L. Strombom, A. Stahlberg, N. Zoric The real-time polymerase chain reaction. Mol. Aspects Med. 2006, 27, 95.
52. J. Beyene, D. Tritchler, S.B. Bull, K.C. Cartier, G. Jonasdottir, A.T. Kraja, N. Li, N.L. Nock, E. Parkhomenko, J.S. Rao, C.M. Stein, R. Sutradhar, S. Waaijenborg, K.S. Wang, Y. Wang, P. Wolkow Multivariate analysis of complex gene expression and clinical phenotypes with genetic marker data. Genet. Epidemiol. 2007, 31, S103.
53. C.C. Pritchard, L. Hsu, J. Delrow, P.S. Nelson Project normal: defining normal variance in mouse gene expression. Proc. Natl. Acad. Sci. USA 2001, 98, 13266.